Search results
Results from the WOW.Com Content Network
Proliferation, as one of the hallmarks and most fundamental biological processes in tumors, [1] is associated with tumor progression, response to therapy, and cancer patient survival. [2] Consequently, the evaluation of a tumor proliferative index (or growth fraction) has clinical significance in characterizing many solid tumors and hematologic ...
This model allows for much more variation and has been proven to better predict growth." [12] The hyperbolastic growth models H1, H2, and H3 have been applied to analyze the growth of solid Ehrlich carcinoma using a variety of treatments. [13] In animal science, [14] the hyperbolastic functions have been used for modeling broiler chicken growth.
The Nottingham prognostic index (NPI) is used to determine prognosis following surgery for breast cancer. [1] [2] Its value is calculated using three pathological criteria: the size of the tumour; the number of involved lymph nodes; and the grade of the tumour. [1] It is calculated to select patients for adjuvant treatment.
Cancer staging can be divided into a clinical stage and a pathologic stage. In the TNM (Tumor, Node, Metastasis) system, clinical stage and pathologic stage are denoted by a small "c" or "p" before the stage (e.g., cT3N1M0 or pT2N0). This staging system is used for most forms of cancer, except brain tumors and hematological malignancies.
is the initial rate of tumor growth; This function consideration of the plateau cell number makes it useful in accurately mimicking real-life population dynamics. The function also adheres to the sigmoid function, which is the most widely accepted convention of generally detailing a population's growth.
Conventional CT and MRI should be performed with cuts of 10 mm or less in slice thickness contiguously. Spiral CT should be performed using a 5 mm contiguous reconstruction algorithm. This applies to tumors of the chest, abdomen and pelvis. Head and neck tumors and those of extremities usually require specific protocols.
For example, with an annual growth rate of 4.8% the doubling time is 14.78 years, and a doubling time of 10 years corresponds to a growth rate between 7% and 7.5% (actually about 7.18%). When applied to the constant growth in consumption of a resource, the total amount consumed in one doubling period equals the total amount consumed in all ...
MRI scans of a patient with astrocytoma, showing the tumor's progression between the incidental finding in 2007 and the onset of phenotypical changes in 2014. Tumor progression is the third and last phase in tumor development. [1] This phase is characterised by increased growth speed and invasiveness of the tumor cells.